Oncotalks | Powered by Novartis

Section 4: COVID-19: Impact on the Department of Dermatology including testing strategy (Prof. Reinhard Dummer)

Hungary

00:11:17

Navigating Cancer in the Age of COVID-19_Video1

At Novartis Oncology, we are deeply grateful for the strong healthcare professionals who are on the front lines of the COVID19 pandemic treating patients. We understand that the pandemic has created uncertainty and anxiety, including concern about disruption in cancer care. To help the cancer community navigate this unprecedented time, we are bringing together oncology experts to share their insights and offer hope. Check out the discussion between Susanne Schaffert, PhD, and Dr. Fatima Cardoso, Director of the Breast Cancer Unit at Champalimaud Cancer Center in Lisbon, Portugal

Hungary

00:16:32

Section 2: Melanoma Therapy during COVID-19 Pandemic - Focus on Adverse Events (Prof. Dirk Schadendorf)

Switzerland , Hungary

00:14:44

Section 3: Cancer patients are at increased risk for COVID-19 - Learnings from Wuhan (Prof. Dirk Schadendorf)

Switzerland , Hungary

00:04:31

Section 5: Q&A (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)

Switzerland , Hungary

00:23:47

Full Video: Meet the Experts: Melanoma therapy during COVID-19 pandemic (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)

Full Video: Meet the Experts: Melanoma therapy during COVID-19 pandemic (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)The Virtual Meet the expert Event took place on the 14th of April 2020Swiss approval code:1332629

Switzerland , Hungary

00:57:38

Section 1: Welcome and Introduction (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)

Section 1: Welcome and Introduction (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)The Virtual Meet the expert Event took place on the 14th of April

Switzerland , Hungary

00:02:45

SABCS 2019 - Patrick Neven; PD2-08 Gene expression analysis and association with treatment response in postmenopausal patients with hormone receptor-positive, HER2-negative advanced breast cancer in the MONALEESA-3 study

Patrick Neven is commenting on the poster: PD2-08 Gene expression analysis and association with treatment response in postmenopausal patients with hormone receptor-positive, HER2-negative advanced breast cancer in the MONALEESA-3 study

SABC , Kisqali Channel , Hungary , Lithuania , Albania

00:02:25

SABCS 2019 - Elisabetta Munzone; Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2- advanced breast cancer

Elisabetta Munzone is commenting on the poster: P1-19-06 Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2- advanced breast cancer

SABC , Hungary , Lithuania , Albania , Slovenia

00:04:06

ESMO 2019 Conleth Murphy, MD, PhD; Overall survival (OS) results of the Phase III MONALEESA-3 trial

Conleth Murphy, MD, PhD from the Bon Secours Cork Cancer Centre, Cork, Ireland is commenting on the abstract LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2−) advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB)

ESMO , Kisqali Channel , Hungary , Lithuania , Albania

00:03:01

ESMO 2019 Rachel Giles, PhD; Diagnosis, management, and burden of renal cell carcinomas

Rachel Giles, PhD from Medicom Medical Publishers, Utrecht, The Netherlands is commenting on the abstract: 915PD - Diagnosis, management, and burden of renal cell carcinomas: Results from a global patient survey in 43 countries

ESMO , Hungary , Lithuania , Albania

00:05:16

ESMO 2019 Piotr Rutowski, MD, PhD; Multidisciplinary session: Perioperative therapy in melanoma

Piotr Rutowski, MD, PhD from the Maria Sklodowska-Curie Memorial Cancer Center and Institute, Warsaw, Poland is commenting on the session he chaired: Multidisciplinary session: Perioperative therapy in melanoma

ESMO , Hungary , Lithuania , Albania

00:06:30

Hungary

Section 4: COVID-19: Impact on the Department of Dermatology including testing strategy (Prof. Reinhard Dummer)​

Navigating Cancer in the Age of COVID-19_Video1

Section 2: Melanoma Therapy during COVID-19 Pandemic - Focus on Adverse Events (Prof. Dirk Schadendorf)​

Section 3: Cancer patients are at increased risk for COVID-19 - Learnings from Wuhan (Prof. Dirk Schadendorf)​

Section 5: Q&A (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)

Full Video: Meet the Experts: Melanoma therapy during COVID-19 pandemic (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)​

Section 1: Welcome and Introduction (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)

SABCS 2019 - Patrick Neven; PD2-08 Gene expression analysis and association with treatment response in postmenopausal patients with hormone receptor-positive, HER2-negative advanced breast cancer in the MONALEESA-3 study

SABCS 2019 - Elisabetta Munzone; Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2- advanced breast cancer

ESMO 2019 Conleth Murphy, MD, PhD; Overall survival (OS) results of the Phase III MONALEESA-3 trial

ESMO 2019 Rachel Giles, PhD; Diagnosis, management, and burden of renal cell carcinomas

ESMO 2019 Piotr Rutowski, MD, PhD; Multidisciplinary session: Perioperative therapy in melanoma​

Section 4: COVID-19: Impact on the Department of Dermatology including testing strategy (Prof. Reinhard Dummer)

Section 2: Melanoma Therapy during COVID-19 Pandemic - Focus on Adverse Events (Prof. Dirk Schadendorf)

Section 3: Cancer patients are at increased risk for COVID-19 - Learnings from Wuhan (Prof. Dirk Schadendorf)

Full Video: Meet the Experts: Melanoma therapy during COVID-19 pandemic (Prof. Reinhard Dummer & Prof. Dirk Schadendorf)

ESMO 2019 Piotr Rutowski, MD, PhD; Multidisciplinary session: Perioperative therapy in melanoma